by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
Reacta Healthcare announces successful completion of £1m food allergy paediatric diagnostics project substantially funded by Innovate UK. Reacta Healthcare, a clinical diagnostic company dedicated to providing innovative diagnostics for life-threatening food...
by Reacta Healthcare | Nov 4, 2024 | Appointments, Business News
Reacta Healthcare strengthens Advisory Board in preparation for significant R&D and regulatory activities Reacta Healthcare’s Advisory Board brings a wealth of knowledge and expertise to the business, ensuring that the company objectives are aligned to our...
by Reacta Healthcare | Nov 4, 2024 | Appointments, Business News
Simon Thelwall-Jones appointed as CFO Reacta Healthcare Press Release – 23 November 2023 Reacta Healthcare bolsters Board & Executive Team with the appointment of Simon Thelwall-Jones as Chief Financial Officer. In line with the company growth strategy and...
by Reacta Healthcare | Nov 4, 2024 | Appointments, Business News
Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs Posted on June 27, 2023 Reacta Healthcare appoints Kevin Hawkins as Head of Regulatory Affairs Mr. Hawkins is a pharma veteran with leadership experience spanning R&D, regulatory affairs,...
by Reacta Healthcare | Nov 4, 2024 | Business News, Partnerships
New partnership with FAACT – Food Allergy & Anaphylaxis Connection Team Posted on June 21, 2023 Reacta Healthcare is proud to partner with FAACT to support the needs of the food allergy community. FAACT’s mission is to educate, advocate, and raise awareness for...
by Reacta Healthcare | Nov 4, 2024 | Business News, Investor News
First major milestone reached for Reacta Healthcare £1m Innovate UK funded project Posted on February 10, 2023 Reacta Healthcare is helping combat food allergies amongst paediatrics, addressing the unmet need for greater research and clinical practice in children to...
